NPS PHARMACEUTICALS INC — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c6700ca6-cd87-4244-8dac-96399027dbf1/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2014 | $-8.7M | 2014-01-01 – 2014-12-31 | evidence 0001136261-15-000049 |
| FY 2013 | $-13.5M | 2013-01-01 – 2013-12-31 | evidence 0001136261-14-000082 |
| FY 2012 | $-18.7M | 2012-01-01 – 2012-12-31 | evidence 0001136261-13-000114 |
| FY 2011 | $-36.3M | 2011-01-01 – 2011-12-31 | evidence 0001136261-13-000114 |
| FY 2010 | $-31.4M | 2010-01-01 – 2010-12-31 | evidence 0001136261-13-000114 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NPS PHARMACEUTICALS INC — all facts · Revenue · Operating Income